{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:47:18Z","timestamp":1777520838803,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bcp.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T18:49:08Z","timestamp":1351104548000},"page":"257-264","source":"Crossref","is-referenced-by-count":43,"title":["Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-\u03b4 agonism correlates with impaired NLRP3 inflammasome activation"],"prefix":"10.1016","volume":"85","author":[{"given":"Massimo","family":"Collino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Rogazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Mastrocola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed M.","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Aragno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Thiemermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Fantozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2337\/db12-0272","article-title":"Outstanding scientific achievement award lecture 2011: defeating diabesity: the case for personalized combinatorial therapies","volume":"61","author":"Tschop","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.014_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4239\/wjd.v2.i6.77","article-title":"High dietary fructose intake: sweet or bitter life","volume":"2","author":"Collino","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/j.bcp.2012.10.014_bib0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07315724.2009.10719794","article-title":"The effects of high fructose syrup","volume":"28","author":"Moeller","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.bcp.2012.10.014_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00019.2009","article-title":"Metabolic effects of fructose and the worldwide increase in obesity","volume":"90","author":"Tappy","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2012.10.014_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.10.014_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrendo.2009.62","article-title":"The role of interleukins in insulin resistance and type 2 diabetes mellitus","volume":"5","author":"Feve","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0035","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.10.014_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2012.10.014_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2012.10.014_bib0050","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.014_bib0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187153011797881175","article-title":"The role of PPARbeta\/delta in the management of metabolic syndrome and its associated cardiovascular complications","volume":"11","author":"Benetti","year":"2011","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.bcp.2012.10.014_bib0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/rccm.201002-0240OC","article-title":"Protective role of peroxisome proliferator-activated receptor-beta\/delta in septic shock","volume":"182","author":"Kapoor","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2012.10.014_bib0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2010.02.012","article-title":"High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels","volume":"97","author":"Bocarsly","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2012.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/oby.2009.502","article-title":"Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat","volume":"18","author":"Collison","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bcp.2012.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0960-894X(03)00207-5","article-title":"Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta) \u2013 synthesis and biological activity","volume":"13","author":"Sznaidman","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2012.10.014_bib0080","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1073\/pnas.0708647105","article-title":"PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis","volume":"105","author":"Takata","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.10.014_bib0085","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1476-5381.2010.00671.x","article-title":"Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation","volume":"160","author":"Collino","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2010.10.710","article-title":"Peroxisome proliferator-activated receptor beta\/delta agonism protects the kidney against ischemia\/reperfusion injury in diabetic rats","volume":"50","author":"Collino","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bcp.2012.10.014_bib0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00360-008-0291-7","article-title":"Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?","volume":"179","author":"Johnson","year":"2009","journal-title":"J Comp Physiol B"},{"key":"10.1016\/j.bcp.2012.10.014_bib0100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1523-1755.2003.00840.x","article-title":"Pathophysiology of proteinuria","volume":"63","author":"D\u2019Amico","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2012.10.014_bib0105","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc10-1079","article-title":"Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis","volume":"33","author":"Malik","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2012.10.014_bib0110","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/jama.2010.449","article-title":"Caloric sweetener consumption and dyslipidemia among US adults","volume":"303","author":"Welsh","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2012.10.014_bib0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ki.2009.543","article-title":"Sugar-sweetened beverages and chronic disease","volume":"77","author":"Curhan","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2012.10.014_bib0120","doi-asserted-by":"crossref","first-page":"e3431","DOI":"10.1371\/journal.pone.0003431","article-title":"Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999\u20132004","volume":"3","author":"Shoham","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2012.10.014_bib0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2006.07.004","article-title":"The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression","volume":"113","author":"Kim","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2012.10.014_bib0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2012.10.014_bib0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2011.06.008","article-title":"Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake","volume":"343","author":"Tatarczyk","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2012.10.014_bib0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1210\/en.2010-1468","article-title":"The PPARbeta\/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation","volume":"152","author":"Barroso","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2012.10.014_bib0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1476-5381.2011.01240.x","article-title":"PPARdelta agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle","volume":"163","author":"Ye","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0031-1280781","article-title":"Pharmacological activation of peroxisome proliferator-activated receptor delta improves insulin resistance and hepatic steatosis in high fat diet-induced diabetic mice","volume":"43","author":"Wu","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bcp.2012.10.014_bib0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.10.014_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5381.2010.01032.x","article-title":"The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury","volume":"162","author":"Miglio","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.taap.2010.11.011","article-title":"Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment","volume":"251","author":"Vila","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0175","first-page":"455","article-title":"Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet","volume":"99","author":"Korieh","year":"1991","journal-title":"Arch Int Physiol Biochim Biophys"},{"key":"10.1016\/j.bcp.2012.10.014_bib0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jnutbio.2011.09.006","article-title":"The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease","volume":"23","author":"Nomura","year":"2012","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bcp.2012.10.014_bib0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.semnephrol.2011.08.006","article-title":"Uric acid and fructose: potential biological mechanisms","volume":"31","author":"Lanaspa","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2012.10.014_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats","volume":"67","author":"Sanchez-Lozada","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.bcp.2012.10.014_bib0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2010080798","article-title":"The inflammasomes in kidney disease","volume":"22","author":"Anders","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bcp.2012.03.005","article-title":"Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats","volume":"84","author":"Hu","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0215","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood.V99.11.4160","article-title":"Neutrophil activation by heme: implications for inflammatory processes","volume":"99","author":"Graca-Souza","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.10.014_bib0220","first-page":"800","article-title":"Peroxynitrite plays a key role in glomerular lesions in diabetic rats","volume":"22","author":"Xiao","year":"2009","journal-title":"J Nephrol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.33549\/physiolres.930343","article-title":"Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation","volume":"53","author":"Altannavch","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.bcp.2012.10.014_bib0230","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s001250051567","article-title":"High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent","volume":"43","author":"Park","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2012.10.014_bib0235","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1681\/ASN.2004090802","article-title":"Peroxisome proliferator-activated receptor beta\/delta exerts a strong protection from ischemic acute renal failure","volume":"16","author":"Letavernier","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2012.10.014_bib0240","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2012.10.014_bib0245","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2012.10.014_bib0250","first-page":"9999","article-title":"Effect of anti-IL-1beta antibody (Canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial","author":"Rissanen","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bcp.2012.10.014_bib0255","doi-asserted-by":"crossref","first-page":"G253","DOI":"10.1152\/ajpgi.00397.2010","article-title":"Developmental control of the NLRP6 inflammasome and a substrate, IL-18, in mammalian intestine","volume":"300","author":"Kempster","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"updated-by":[{"DOI":"10.1016\/j.bcp.2024.116060","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:43:47Z","timestamp":1687776227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212006909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0006295212006909"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.10.014","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}